Dhanuka Agritech has launched POLIN, a new-generation fungicide for the domestic market in India. Developed in collaboration with Nippon-Soda, Japan, the product introduces a novel DHODHI mode of action to enhance crop protection.

Product specifications and mode of action

POLIN (20% SC) is designed to provide preventive protection against Leaf and Neck Blast. The formulation utilizes a novel DHODHI mode of action, classified under FRAC 52. This mechanism offers translaminar and systemic action, ensuring longer-lasting protection for crops compared to conventional fungicides.

Strategic collaboration

The development of POLIN marks a technical partnership between Dhanuka Agritech and Nippon-Soda. By leveraging Nippon-Soda's research capabilities, the company aims to address resistance issues in fungal pathogens through this unique chemical class. The launch is strictly for the Indian market, aligning with the company's focus on strengthening its domestic portfolio with innovative solutions.

Dhanuka Agritech has received in-principle approval from the National Stock Exchange of India Limited (NSE) and BSE Limited for the listing of up to 50,000 equity shares. The shares are to be issued under the Dhanuka Employee Stock Option Plan 2026 (ESOP 2026).

The exchange approvals were granted on September 16, 2026. Each equity share carries a face value of ₹2. The allotment is restricted to permanent employees of the company, as per undertakings provided under Regulation 10(b) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Listing Conditions

The in-principle approvals are subject to several compliance requirements before final listing and trading permissions are issued. Key conditions include:

• Notification to the exchanges as per Regulation 10(c) along with a listing application after share allotment.
• Credit of securities to beneficiary accounts or dispatch of share certificates by the Registrar and Transfer agent.
• Receipt of statutory approvals from authorities including SEBI, RBI, and MCA.
• Compliance with all guidelines, regulations, and directions of the exchanges and statutory bodies.
• Adherence to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.

Regulatory Framework

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company must submit certified true copies of board resolutions, lists of allottees, and details of employees granted options exceeding specific thresholds.

The exchanges reserve the right to withdraw the in-principle approval if submitted information is found to be incomplete, incorrect, or misleading. Final trading permission will be issued only after the company fulfills all stated conditions and submits the required documentation.